Redefining care for all means coming together as one community to address how we can partner together to expand equitable access to precision medicine at the policy level. Doing so will help ensure that people with cancer receive the right treatments at the right time and have access to potentially life-saving screens and biomarker tests to best inform treatment decisions.
YOUR Cancer Precision Medicine Roundtables convene influential organizations and individuals in states across the country to meet with their respective policy makers and discuss barriers to precision medicine with a goal of identifying tangible policy measures that ultimately help support people with cancer.
Discussions focus on overcoming barriers to precision medicine access, emphasizing potential policy solutions across four key topics:
Precision medicines are quickly being approved, challenging health professionals and people with cancer to stay abreast of new treatments and testing requirements to improve treatment decisions.
Key decisions regarding genetic sequencing often don't involve the entire treatment team, which can hinder uptake of novel technologies and diminish outcomes.
High standards for demonstrating clinical and economic utility can pose coverage and payment challenges for treatment informed by novel diagnostics.
Legacy informatics systems used by most hospitals are unable to manage the growing breadth and complexity of patient data, sometimes challenging clinicians to incorporate them into clinical practice.